The Japanese government has also included semaglutide (Wegovy) under Japans national health insurance since February 2024
[26] Constipation is another common side effect of GLP-1 medications, and relying heavily on protein shakes without adequate fibre intake can worsen this issue
Driven by the hypothesis that Long COVID is fundamentally rooted in neuroinflammation and mitochondrial dysfunction, clinical trials have begun testing metabolic interventions
At the same time, history offers numerous examples of treatments that appeared promising early on but later revealed safety concerns, unexpected adverse effects, or limited long-term benefit
Such investigations contribute to a deeper understanding of biological systems and support the development of future scientific discoveries
Due to the N-terminal truncation, PYY (3-36) shows high selectivity and affinity for Y2 receptors (45), retaining part of the activity on Y5 receptors (46), but the binding ability to Y1 and Y4 receptors is greatly reduced (47)